Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED
December 22, 2022
December 22, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Bausch + Lomb.
- Optometrists — maximum of 1.25 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed towards ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with dry eye disease and meibomian gland dysfunction.
This Expert Illustrations and Commentaries™ is a video-based program in which two experts discuss the management of meibomian gland dysfunction (MGD)-associated dry eye disease (DED). In this activity, the faculty focus on the etiology of MGD-associated DED and current and emerging therapeutic strategies for its management. Their discussion is enriched with the use of video animation to illustrate the pathophysiology of MGD and mechanisms of action of emerging agents. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of MGD-associated DED and to improve outcomes for their patients with this disease.
- Describe the impact that MGD-associated DED has on patients’ quality of life
- Assess the efficacy and safety of currently available agents used for the treatment of MGD-associated DED
- Identify the MOAs of new and emerging agents for the treatment of MGD-associated DED
- Evaluate clinical trial data for new and emerging agents in the treatment of MGD-associated DED
Eric Donnenfeld, MD
Ophthalmic Consultants of Long Island
Clinical Professor of Ophthalmology NYU
Board of Overseers, Dartmouth Medical School
New York, NY
Walter Whitley, OD, MBA
Director of Professional Relations and Education
Virginia Eye Consultants
Regional Medical Director- Mid-Atlantic
EyeCare Partners, LLC
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours.
Physicians’ Education Resource®, LLC (PER) is accredited by COPE to provide continuing education to optometrists.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.
- Eric Donnenfeld, MD
- Consultant: Allergan, Alcon, Azura, Bausch + Lomb, Johnson & Johnson, Tarsus, Tear Science
- Walter Whitley, OD, MBA
- Grant/Research Support: Heru
- Consultant: Alcon, Allergan, Bausch + Lomb, Bruder, Kala, Oyster Point, Santen, Sun
- Speaker’s Bureau: Alcon, Allergan, Bausch + Lomb, Sun, Oyster Point
- Stock/Shareholder: Mediprint Pharma, Regener-Eyes
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.